Why the study?
Acquired von Willebrand syndrome is a rare, frequently underdiagnosed bleeding disorder whose evaluation and management are complex due to the requirement for multiple laboratory assays.
Von Willebrand factor multimeric analysis is a valuable tool in diagnosing acquired von Willebrand syndrome, with lower high-molecular weight multimers correlating with bleeding severity.
Case series of seven AVWS patients underscores diagnostic complexity; leaves open prevalence and management questions for larger studies.
Objectives Acquired von Willebrand syndrome (AVWS) is a rare and frequently underdiagnosed bleeding disorder with an unknown prevalence. The diagnosis of AVWS is made based on laboratory investigations and the presence of clinical symptoms. Evaluation and management of affected patients are complex due to the need for multiple laboratory assays. Materials and Methods Here, we describe the clinical and laboratory data of seven patients with a diagnosis of AVWS. All patients met the criteria for AVWS based on laboratory findings, bleeding symptoms, and the absence of any previous history of a bleeding disorder. Results In all cases, the laboratory findings, lack of bleeding anamnesis, and family history suggested the presence of AVWS. Von Willebrand factor multimeric analysis showed decreased high-molecular weight (HMW) multimers in six cases. Patients with lower HMW multimers experienced more severe bleeding complications. Conclusions The diagnosis of AVWS is complex and requires extensive laboratory evaluation. Interdisciplinary collaboration and complex laboratory evaluations are of paramount importance for the early recognition of AVWS and optimal AVWS diagnosis as well as successful clinical management.
No takes yet. Share an insight, caveat, or question.
Pikta et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: